Literature DB >> 32139664

Long Non-Coding RNA Taurine Upregulated Gene 1 (TUG1) Downregulation Constrains Cell Proliferation and Invasion through Regulating Cell Division Cycle 42 (CDC42) Expression Via MiR-498 in Esophageal Squamous Cell Carcinoma Cells.

Zhifeng Wang1, Jingmei Liu2, Rong Wang1, Qinqin Wang3, Rong Liang1, Jinliang Tang4.   

Abstract

BACKGROUND Esophageal squamous cell carcinoma (ESCC) is a malignant tumor of the gastrointestinal tract. Taurine upregulated gene 1 (TUG1), a long non-coding (lnc) RNA, also known as LIN00080 or TI-227H, was connected with the tumorigenesis of various diseases. Hence, we plumed the role and molecular mechanism of TUG1 in the progression of ESCC. MATERIAL AND METHODS Expression patterns of TUG1, microRNA-498 (miR-498), and cell division cycle 42 (CDC42) mRNA were assessed using quantitative real time polymerase chain reaction (qRT-PCR). The expression level of CDC42 protein was evaluated via western blot analysis. Cell proliferation and invasion were determined with Cell Counting Kit-8 (CCK-8) assay or Transwell assay. The relationship between miR-498 and TUG1 or CDC42 was predicted by online bioinformatics database LncBase Predicted v.2 or microT-CDS and confirmed through dual-luciferase reporter system or RNA immunoprecipitation assay (RIP). RESULTS TUG1 and CDC42 were upregulated while miR-498 was strikingly decreased in ESCC tissues and cells (P<0.0001). Besides, TUG1 suppression blocked the proliferation and invasion of ESCC cells (P<0.001). Importantly, TUG1 decrease restrained CDC42 expression via binding to miR-498 in ESCC cells. Also, the suppressive impacts of TUG1 silencing on the proliferation and invasion of ESCC cells were mitigated by miR-498 reduction. Meanwhile, the repression of proliferation and invasion induced by miR-498 elevation was weakened by CDC42 overexpression. CONCLUSIONS Inhibition of TUG1 hampered cell proliferation and invasion by downregulating CDC42 via upregulating miR-498 in ESCC cells. Thus, TUG1 might be an underlying therapeutic target for ESCC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32139664     DOI: 10.12659/MSM.919714

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  10 in total

1.  Cell division control 42 elevates during infliximab therapy, and its increment relates to treatment response in ulcerative colitis patients.

Authors:  Lin Liu; Qinger Liu; Jian Chang; Xiaoxia Dong; Weiping Ma
Journal:  J Clin Lab Anal       Date:  2022-05-09       Impact factor: 3.124

2.  LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis.

Authors:  Cui-Juan Qian; Zhu-Rong Xu; Lu-Yan Chen; Yi-Chao Wang; Jun Yao
Journal:  Cancer Manag Res       Date:  2020-08-05       Impact factor: 3.989

3.  Silencing lncRNA AFAP1-AS1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma Cells via Regulating the miR-498/VEGFA Axis.

Authors:  Wenhao Shen; Lei Yu; Aihua Cong; Song Yang; Peng Wang; Gaohua Han; Bin Gu; Wei Zhang
Journal:  Cancer Manag Res       Date:  2020-07-29       Impact factor: 3.989

4.  LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non-small cell lung cancer.

Authors:  Dongping Chen; Yashan Li; Yukang Wang; Jinlian Xu
Journal:  Genes Genomics       Date:  2021-02-03       Impact factor: 1.839

5.  Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.

Authors:  Jie Yan; Daihong Wan
Journal:  J Clin Lab Anal       Date:  2021-12-24       Impact factor: 2.352

6.  LncRNA Taurine Upregulated Gene 1 as a Potential Biomarker in the Clinicopathology and Prognosis of Multiple Malignant Tumors: A Meta-Analysis.

Authors:  Qi Huang; Jingjing Wu; Hui Wang; Na Li; Zhen Yang; Mingjun Zhang
Journal:  Dis Markers       Date:  2021-03-02       Impact factor: 3.434

Review 7.  Role of long noncoding RNA taurine-upregulated gene 1 in cancers.

Authors:  Miao Da; Jing Zhuang; Yani Zhou; Quan Qi; Shuwen Han
Journal:  Mol Med       Date:  2021-05-26       Impact factor: 6.354

8.  The relationship of blood CDC42 level with Th1 cells, Th17 cells, inflammation markers, disease risk/activity, and treatment efficacy of rheumatoid arthritis.

Authors:  Yongji Li; Wendi Yang; Feng Wang
Journal:  Ir J Med Sci       Date:  2021-12-02       Impact factor: 2.089

9.  LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis.

Authors:  Zhenkun Yan; Miaomiao Bi; Qiyu Zhang; Yumei Song; Sen Hong
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

10.  PBMC CDC42 reveals the disease activity and treatment efficacy of TNF inhibitor in patients with ankylosing spondylitis.

Authors:  Qian Zhang; Du Jin; Xiaoyue Mou; Hengli Ye
Journal:  J Clin Lab Anal       Date:  2022-02-01       Impact factor: 2.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.